ACER - Acer Therapeutics GAAP EPS of -$0.17 beats by $0.42 August, 15 2022 05:26 PM Acer Therapeutics Inc. Acer Therapeutics press release ( NASDAQ: ACER ): Q2 GAAP EPS of -$0.17 beats by $0.42 . Cash and cash equivalents were $14.5 million For further details see: Acer Therapeutics GAAP EPS of -$0.17 beats by $0.42